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INTRODUCTION:  Acute  acalculous  cholecystitis  (AAC)  is  rarely  encountered  in clinical  practice  and  has  a
high morbidity  and  mortality.  AAC  caused  by  viral  hepatitis,  with  hepatitis  A,  B  and  EBV  infections  are
rare,  but  well  documented  in the  literature.  Hepatitis  C virus  has  not  been  reported  as  cause  of AAC.  This
case  report  documents  the  ﬁrst  case  of AAC  associated  with  Acute  Hepatitis  C.
PRESENTING  CONCERNS:  We  present  a 40 years  old  female  with  abdominal  pain. She  has  a  history  of
previous  HCV infection.  Her  liver  function  tests  were  markedly  deranged  with  elevated  inﬂammatory
markers.  USS  scan  showed  rather  a very  unusual  appearance  of an  inﬂamed  gallbladder  with  no  gallstones
and  associated  acute  hepatitis,  conﬁrmed  by  an  abdominal  CT  scan.  HCV RNA  PCR conﬁrms  ﬂair  up  of  the
virus.  The  patient  was  managed  conservatively  in  the  hospital  with  follow  up USS  scan  and  Liver function
tests  showed  complete  recovery.  Follow  up  HCV  RNA PCR  also  returned  to an undetectable  level. The
patient  recovered  completely  with  no adverse  outcomes.
CONCLUSION:  This case  report  is to  the  ﬁrst  to document  the  association  between  acute  HCV  and  AAC.
Despite  being  uncommon  in western  countries,  viral  hepatitis  should  be suspected  as  a causative  agent
of AAC,  particularly  when  there  is  abnormal  liver  function  test  and  no  biliary  obstruction.
©  2015  The  Authors.  Published  by  Elsevier  Ltd.  on behalf  of IJS  Publishing  Group  Ltd.  This  is an  open
access  article  under  the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).. Introduction
Acute cholecystitis is a common surgical problem. It is histor-
cally classiﬁed as either being of acute calculous or acalculous,
ith the former accounting for 90% of cases of acute cholecystitis.
iagnosis of acalculous cholecystitis is conﬁrmed when acute gall-
ladder inﬂammation is not associated with gallstones or sludge,
 rare condition that carries high morbidity and mortality [1]. It
s associated with a variety of clinical conditions. The majority of
ases occurs after surgical intervention (47%) with the remaining
ases associated with prolonged immobilization, severe sepsis, and
ong-standing malnutrition [2–4].
Viral hepatitis is a rare cause of acalculous cholecystitis, with
 handful of cases reported to be linked to hepatitis A, hepatitis B
nd EBV [5–11]. Up to date search to medline data base shows no
eference to Hepatitis C virus (HCV) infection and its association to
AC. This case report document the ﬁrst association between HCV
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ttp://dx.doi.org/10.1016/j.ijscr.2015.12.020
210-2612/© 2015 The Authors. Published by Elsevier Ltd. on behalf of IJS Publishing 
reativecommons.org/licenses/by-nc-nd/4.0/).and AAC and the challenge to conﬁrm this association. This case
report is complaint with CARE criteria as published in 2013 [19].
2. Presentation of case
A 40 years old female patient presented to the emergency
department at Wanganui hospital, with a history of progressive
upper abdominal pain, and nausea and vomiting for one week. She
had also noticed increasing darker urine but no haematuria, no pale
stools and no fevers.
She had a history of previous Hepatitis C infection, post-
traumatic stress syndrome, anxiety and depression. She had no
previous surgery. Her regular medications included Ritalin 150 mg
daily, Clonazepam 4 mg  daily, Zopiclone 7.5 mg  daily. She had a
history of previous intravenous drug abuse 20 years ago, as well as
multiple skin piercings and tattoos. She lives at home with her hus-
band and two children. She is a smoker of about 10–15 cigarettes
per day for the past 15 years. No history of alcohol abuse.
On examination, she was  acutely unwell, in severe pain which
was poorly controlled with opioids, with a tachycardia of 110
beats/min and blood pressure of 110/70 mm Hg. Her tempera-
ture was 37.8 ◦C. She was  clinically jaundiced, but had no signs
of chronic liver disease. Abdominal examination showed a tender
Group Ltd. This is an open access article under the CC BY-NC-ND license (http://
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Fig. 1. Transabdominal ultrasound scan showed diffuse thickening of the gallblad-
der  wall (up to 20 mm  thick) with a lamellated hypoechoic appearance to the wall
(arrow). The mucosa of gallbladder is seen in the middle of gallbladder with no
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Fig. 2. Abdominal computerized tomography coronal and cross-sectional views
in the wall of the gallbladder secondary to over activation of fac-
tor XII-dependant coagulation pathway [15]. This process starts asumen.
pper abdomen with percussion tenderness, mostly in the right
pper quadrant (Positive Murphy sign), with an enlarged liver.
.1. Diagnostic approach
Blood tests revealed normal WBC  count of 8.9 × 109/L, slightly
levated CRP (40) on initial presentation, with thrombocytopenia
platelets count 77 × 109/L). Liver function tests indicated acute
epatitis, with total bilirubin of 155 mol/L (normal 2–20), Alka-
ine Phosphatase 243 U/L (normal 20–29), ALT 2171 U/L (5–30),
ST 1646 U/L (10–30), serum albumin 30 g/L (34–48), coagulation
nternational normalized ratio-INR 1.3 (0.8–1.1). Pancreatic amy-
ase was normal 15 U/L (8–53) and kidney function tests were also
ormal.
An abdominal ultrasound scan revealed moderate hep-
tomegaly with increased echogenicity, no focal lesions, normal
alibre of common bile duct, with diffuse thickening of the gall-
ladder wall (up to 20 mm)  with lamellated hypoechoic appearance
ithout gallstones and no peri-cystic ﬂuid collection (Fig. 1). Vas-
ular ﬂow was demonstrated in the wall of gallbladder. Normal
lood ﬂow was seen in the portal vein, with no dilatation. Min-
mal ascites was present in the peritoneal cavity. These ﬁndings
rompted further imaging with CT abdomen.
The abdominal CT scan with intravenous contrast revealed
n enhanced gallbladder mucosa with marked thickening of the
all, rather unusual radiological features of acutely inﬂamed gall-
ladder. There was also minimal peri-cystic ﬂuid collection with
ncrease density around the portal vein which was suggestive of
edema, likely due to acute hepatitis. A small amount of ascitic
uid was observed. (Fig. 2). The contrast perfusion of the liver in
he arterial phase showed a geographic streaky hyperdensity in the
ight lobe of the liver, but homogeneous perfusion in the venous
hase indicated hepatic perfusion in acute hepatitis. The liver was
arkedly enlarged, with no focal lesion. A normal spleen was  seen.showed the markedly enhanced gallbladder, with a markedly thickened and hypo-
dense gallbladder wall. There was also a peri-cystic ﬂuid collection and oedema
around the portal vein branches with minimal ascites.
3. Treatment approach
The patient was admitted to the hospital, with interven-
tions from the surgical, medical and mental health departments.
Progression of clinical symptoms and signs of acute hepatic fail-
ure were monitored daily. Hepatitis C PCR (HCV RNA) test on
admission, including genotyping, revealed a viral load of 113225
IU/mL(5.06 log IU/ml), genotype 1 A which previously had been
undetectable. Antinuclear antibodies (ANA) was also positive with
a titre of 160. Anti-doublestrand DNA (ds-DNA) and ENA antibodies
both tested negative.
The patient had a dramatic clinical improvement with conser-
vative management over a week, with improving pain and overall
condition. The improvement also included the liver function tests,
with bilirubin level returning to normal, INR returned to 1.1, and
platelets count improved to 231 × 109/L. The patient was dis-
charged home after a week with complete recovery, followed up
by a hepatologist and the mental health team. A follow up USS scan
after 6 weeks showed complete resolution of acute cholecystitis, a
normal liver appearance, and no ascites (Fig. 3). A repeat HCV RNA
PCR test after eight weeks showed no viral RNA detected. This con-
ﬁrms that the previous attack of AAC was related to an acute ﬂare
up of HCV.
4. Discussion
Acute acalculous cholecystitis (AAC) represents the inﬂamma-
tion of a gallbladder without evidence of gallstones. The condition
is rare [12]. Complications such as perforation, gangrene formation,
and empyema are the causes of the high morbidity and mortality
associated with this condition [13]. The pathogenesis of AAC is yet
to be studied due to its rare frequency. In one review of 15 patients
with AAC, the primary pathological feature was vascular occlusiongallbladder wall oedema that results in decreased perfusion, with
necrosis of the wall of gallbladder if the process of inﬂammation
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Fig. 3. Repeat ultrasound scan after 6 weeks showed complete resolution of gall-
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Table 1
Trend in liver function test over one week from acute attack of AAC.
LFT Day 1 Day 3 One week Units Ref. range
Bilirubin 155 176 20 umol/L 2–10
Alk  phosphatase 243 226 122 U/L 20–90
GGT 94 68 21 U/L 10–35
ALT  2171 1262 74 U/L 5–30ladder oedema and wall thickening. The gallbladder has returned to a normal
ppearance.
ontinues. This inﬂammatory response is exacerbated by factors
uch as prolonged immobilization, starvation and sepsis, which
educes blood ﬂow, resulting in gallbladder wall ischemic injury
16].
In addition to ischemic injury, cholecystokinin (CCK), an impor-
ant hormone secreted after meals, could also play a role in the
athogenesis of AAC. CCK stimulates the gallbladder to contract
nd release the stored bile into the duodenum, which helps the
mulsiﬁcation of fatty food [18]. This action protects the gallblad-
er from the detergent effect of bile, which could lead to epithelial
njury in cases of prolonged exposure [17]. In cases of starvation
nd immobilization, secretion of CCK is reduced signiﬁcantly, even-
ually leading to bile stasis in the gallbladder and exposes the
pithelium to the detergent effect of bile [16].
Viral hepatitis is a very rare cause of AAC and the pathophysi-
logy is not fully understood. Low serum albumin, hepatomegaly
ue to acute inﬂammation, and high portal venous pressure may
xplain gallbladder wall oedema [14]. The most widely accepted
ypothesis is ischemic injury of the gallbladder cells secondary to
mmune complex deposition, particularly in cases of ACC associated
ith hepatitis B virus infection [12]. This hypothesis is supported by
he fact that up to 20% of acute hepatitis B patients develop extra-
epatic complications secondary to immune complex deposition
18].
Hepatitis C-induced AAC has not been reported. In fact, our
earch on the MEDLINE database using the phrases ‘Hepatitis C’ and
acalculous cholecystits’ resulted in only one article titled “Hepatitis
 virus infection revealed by an acute acalculous cholecystitis”- J.
adiol 2010 without further details about the case. This case report
llustrates a very rare cause of AAC with clinical evidence of the dis-
ase and its association with Hepatitis C infection. We  are conﬁdent
hat HCV is the cause of AAC in this case. The HCV RNA PCR conﬁrms
cute ﬂare up of the virus followed by remission with improvement
n the patient’s condition (Table 1).
The key factor in the management is conservative rather than
urgical intervention, with no role for antibiotics in this case. This
ase also highlights the importance of screening for viral hepatitis
hen AAC is suspected, particularly when the liver function test isAST  1646 551 44 U/L 10–30
Total protein 58 48 72 g/L 65–80
Albumin 30 23 33 g/L 34–48
markedly deranged. Antiviral therapy was  not given as the patient
improved over short period of time with return of liver function
and HCV PCR to normal levels. Liver biobsy was not considered as
the LFT and HCV PCR returned back to normal.
Diagnostic challenge was  to conﬁrm that HVC was  the cause of
AAC in this case and to roll out the possibility of autoimmune dis-
ease, particularly with mild elevation in ANA level, but was deemed
unlikely due to a weakly positive ANA. Furthermore, the patient did
improve without steroids which also made an autoimmune cause
very unlikely.
5. Conclusion
Previously, HBV and HAV have been documented as a cause of
AAC but not HCV. In this case report, we  have documented the
association between acute HCV infection and AAC. Recommenda-
tion from this case report that viral hepatitis must be suspected
as a cause of AAC, especially when Liver function test is markedly
deranged and imaging exclude biliary obstruction. Treatment is
conservative and antiviral treatment unlikely to be needed in such
cases. However, further studies are required to evaluate weather
antiviral treatment is required for better outcome.
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